Log In
Print
BCIQ
Print
Print this Print this
 

ficlatuzumab (AV-299)

Also known as: formerly SCH 900105

  Manage Alerts
Collapse Summary General Information
Company Aveo Pharmaceuticals Inc.
DescriptionHuman IgG1 mAb antagonist of the human hepatocyte growth factor/scatter factor (HGF/SF) ligand, a c-Met receptor activator
Molecular Target Hepatocyte growth factor/scatter factor (HGF/SF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today